309 related articles for article (PubMed ID: 9572495)
21. Aryl hydrocarbon receptor-mediated antiestrogenicity in MCF-7 cells: modulation of hormone-induced cell cycle enzymes.
Wang W; Smith R; Safe S
Arch Biochem Biophys; 1998 Aug; 356(2):239-48. PubMed ID: 9705214
[TBL] [Abstract][Full Text] [Related]
22. Induction of cyclins E and A in response to mitogen removal: a basic alteration associated with the arrest of differentiation of C2 myoblasts transformed by simian virus 40 large T antigen.
Tedesco D; Baron L; Fischer-Fantuzzi L; Vesco C
J Virol; 1997 Mar; 71(3):2217-24. PubMed ID: 9032356
[TBL] [Abstract][Full Text] [Related]
23. Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution.
Planas-Silva MD; Weinberg RA
Mol Cell Biol; 1997 Jul; 17(7):4059-69. PubMed ID: 9199341
[TBL] [Abstract][Full Text] [Related]
24. NGF regulates the PC12 cell cycle machinery through specific inhibition of the Cdk kinases and induction of cyclin D1.
Yan GZ; Ziff EB
J Neurosci; 1995 Sep; 15(9):6200-12. PubMed ID: 7666202
[TBL] [Abstract][Full Text] [Related]
25. Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts.
Stein GH; Drullinger LF; Soulard A; Dulić V
Mol Cell Biol; 1999 Mar; 19(3):2109-17. PubMed ID: 10022898
[TBL] [Abstract][Full Text] [Related]
26. Role of cyclin A and p27 in anti-IgM induced G1 growth arrest of murine B-cell lymphomas.
Ezhevsky SA; Toyoshima H; Hunter T; Scott DW
Mol Biol Cell; 1996 Apr; 7(4):553-64. PubMed ID: 8730099
[TBL] [Abstract][Full Text] [Related]
27. p21 is a critical CDK2 regulator essential for proliferation control in Rb-deficient cells.
Brugarolas J; Bronson RT; Jacks T
J Cell Biol; 1998 Apr; 141(2):503-14. PubMed ID: 9548727
[TBL] [Abstract][Full Text] [Related]
28. Cyclin kinase inhibitors are increased during experimental membranous nephropathy: potential role in limiting glomerular epithelial cell proliferation in vivo.
Shankland SJ; Floege J; Thomas SE; Nangaku M; Hugo C; Pippin J; Henne K; Hockenberry DM; Johnson RJ; Couser WG
Kidney Int; 1997 Aug; 52(2):404-13. PubMed ID: 9263996
[TBL] [Abstract][Full Text] [Related]
29. Regulation of cyclin D-dependent kinase activity in rat liver regeneration.
Kato A; Ota S; Bamba H; Wong RM; Ohmura E; Imai Y; Matsuzaki F
Biochem Biophys Res Commun; 1998 Apr; 245(1):70-4. PubMed ID: 9535785
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of the integrin-linked kinase promotes anchorage-independent cell cycle progression.
Radeva G; Petrocelli T; Behrend E; Leung-Hagesteijn C; Filmus J; Slingerland J; Dedhar S
J Biol Chem; 1997 May; 272(21):13937-44. PubMed ID: 9153256
[TBL] [Abstract][Full Text] [Related]
31. Differential patterns of cell cycle regulatory proteins expression in transgenic models of thyroid tumours.
Coppée F; Depoortere F; Bartek J; Ledent C; Parmentier M; Dumont JE
Oncogene; 1998 Aug; 17(5):631-41. PubMed ID: 9704929
[TBL] [Abstract][Full Text] [Related]
32. CaMK-II inhibition reduces cyclin D1 levels and enhances the association of p27kip1 with Cdk2 to cause G1 arrest in NIH 3T3 cells.
Morris TA; DeLorenzo RJ; Tombes RM
Exp Cell Res; 1998 May; 240(2):218-27. PubMed ID: 9596994
[TBL] [Abstract][Full Text] [Related]
33. Arotinoid mofarotene (RO40-8757) up-regulates p21 and p27 during growth inhibition of pancreatic cancer cell lines.
Kawa S; Nikaido T; Aoki Y; Zhai Y; Kumagaya T; Furihata K; Fujii S; Kiyosawa K
Int J Cancer; 1997 Sep; 72(5):906-11. PubMed ID: 9311612
[TBL] [Abstract][Full Text] [Related]
34. Cyclin E-CDK2 is a regulator of p27Kip1.
Sheaff RJ; Groudine M; Gordon M; Roberts JM; Clurman BE
Genes Dev; 1997 Jun; 11(11):1464-78. PubMed ID: 9192873
[TBL] [Abstract][Full Text] [Related]
35. Progesterone inhibits estrogen-induced cyclin D1 and cdk4 nuclear translocation, cyclin E- and cyclin A-cdk2 kinase activation, and cell proliferation in uterine epithelial cells in mice.
Tong W; Pollard JW
Mol Cell Biol; 1999 Mar; 19(3):2251-64. PubMed ID: 10022912
[TBL] [Abstract][Full Text] [Related]
36. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F.
Leone G; DeGregori J; Sears R; Jakoi L; Nevins JR
Nature; 1997 May; 387(6631):422-6. PubMed ID: 9163430
[TBL] [Abstract][Full Text] [Related]
37. New functional activities for the p21 family of CDK inhibitors.
LaBaer J; Garrett MD; Stevenson LF; Slingerland JM; Sandhu C; Chou HS; Fattaey A; Harlow E
Genes Dev; 1997 Apr; 11(7):847-62. PubMed ID: 9106657
[TBL] [Abstract][Full Text] [Related]
38. Cell cycle-dependent phosphorylation of p27 cyclin-dependent kinase (Cdk) inhibitor by cyclin E/Cdk2.
Morisaki H; Fujimoto A; Ando A; Nagata Y; Ikeda K; Nakanishi M
Biochem Biophys Res Commun; 1997 Nov; 240(2):386-90. PubMed ID: 9388487
[TBL] [Abstract][Full Text] [Related]
39. Investigation of the cell cycle regulation of cdk3-associated kinase activity and the role of cdk3 in proliferation and transformation.
Braun K; Hölzl G; Soucek T; Geisen C; Möröy T; Hengstschläger M
Oncogene; 1998 Oct; 17(17):2259-69. PubMed ID: 9811456
[TBL] [Abstract][Full Text] [Related]
40. Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors.
Parry D; Mahony D; Wills K; Lees E
Mol Cell Biol; 1999 Mar; 19(3):1775-83. PubMed ID: 10022865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
